Accretion Nutraveda IPO GMP & Listing Price
SME · ₹129 · BSE SME
IST
GMP vs actual listing
Closed its first day at ₹191.2 (+48.2% on the issue price)
GMP was off by 4.7% on this issue. We publish every miss, not just the hits.
Subscription status
as of 4 Feb, 2:36 pmNot in our records for this issue: Sector, Lot size, Min investment, P/E ratio, Registrar.
Accretion Nutraveda IPO FAQs
What was the listing price of Accretion Nutraveda IPO?
Accretion Nutraveda IPO listed at ₹191 on Wed, 4 Feb, 2026, +48.1% against the issue price of ₹129. The last grey market premium before listing was ₹68, which implied ₹197.
What was the GMP of Accretion Nutraveda IPO before listing?
The last grey market premium for Accretion Nutraveda IPO was ₹68, recorded at 2:36 pm IST on Wed, 4 Feb, 2026. That implied +52.7% over the ₹129 price. The stock actually listed +48.1%, so GMP was off by 4.7%.
When was Accretion Nutraveda IPO allotment and listing?
The allotment date for Accretion Nutraveda IPO is not announced yet and the shares listed on Wed, 4 Feb, 2026 on BSE SME.
GMP is unofficial. Grey market premium is an unregulated, over-the-counter indication with no backing from SEBI, BSE or NSE. It is not a listing-price guarantee and not investment advice. Read the RHP and consult a SEBI-registered adviser before applying.